Les médicaments GLP-1 en point de mire : tendances, besoins et perspectives d'avenir

Obesity and diabetes have been two of the greatest public health challenges for decades. Many different diets and fads have promised the public a quick fix and a path to losing excess weight or resolving their diabetic issues. GLP-1 drugs are revolutionizing medicine and the treatment of patients with diabetes, obesity, and other disorders associated with obesity.

With the growing demand of these drugs, pharmaceutical companies, health care providers, telemedicine companies, and pharmaceutical compounders are facing new challenges with GLP-1s. Organizations need to know how to navigate a complex set of issues, including patent considerations, regulatory issues, lawsuits, and M&A activity. 

Foley’s Health Care & Life Sciences and Innovative Technology sectors invite you to join us for a webinar on how your organization can navigate the crossroads of GLP-1s and prepare for this evolving landscape.

This webinar will explore the following GLP-1 topics:

• An inside look on the U.S. Food & Drug Administration’s (FDA) perspective
• How to prepare and secure your patents and safeguard your intellectual property
• The do’s and don’ts of mergers and acquisitions
• Litigation trends
• Clinical trial considerations

Please click here to watch the recording.

CLE

Les demandes d'accréditation seront soumises à CA, CO, FL, IL, NY, TX, UT, VA et WI. Des certificats de participation uniformes seront fournis aux participants licenciés dans d'autres juridictions afin qu'ils puissent s'inscrire eux-mêmes si leur juridiction le permet.

Foley & Lardner LLP est un fournisseur de MCLE approuvé en Californie, au Colorado, en Illinois, à New York, au Texas et dans l'Utah.
Pour les besoins du crédit CLE de New York, ce programme est approprié à la fois pour les avocats nouvellement admis et pour les avocats expérimentés.

Les certificats de participation seront distribués aux participants éligibles environ huit semaines après le programme, par courrier électronique.

­